The US approves the first drug that treats the disease "fundamental" Alzheimer's

The U.S. Food and Drug Administration (FDA) has approved the use of Aduhelm, a new drug for the treatment of Alzheimer’s, the first to directly treat the “fundamental” pathology of this disease.

As reported by the FDA in a statement, it is in addition to the first new treatment against Alzheimer’s that the US Administration approves against this degenerative disease, which only in this country affects 6.2 million citizens.

New powerful ‘weapons’ against Alzheimer’s arrive

Patricia Matey

The approval of this drug has been accelerated because, according to the FDA, it provides a “significant therapeutic advance” compared to other treatments by reducing “beta amyloid” plaques in the brain, which are a sign of the disease, and therefore considers it “reasonable” to foresee a significant benefit for Alzheimer’s patients.

Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more

Leave a Reply